TMCnet News

Cmed to Present at Dpharm: Disruptive Innovations to Advance Clinical Trials
[September 01, 2015]

Cmed to Present at Dpharm: Disruptive Innovations to Advance Clinical Trials


Cmed, an innovative full service CRO and software developer of smart e-clinical data capture and management technologies, today announced its Chief Executive Officer, Dr. David Connelly, will be presenting at the Dpharm: Disruptive Innovations to Advance Clinical Trials conference being held in Boston, MA, on September 10-11, 2015.

As part of the interview series on Challenging Obsolescence with Disruptive Thinkers, Connelly will be speaking alongside Dr. Anthony Tolcher, Managing Director of START - South Texas Accelerated Research Therapeutics, LLC on Thursday, September 10, 2015 at 3:00 pm in a thought provoking and challenging discussion titled "Will EDC be Obsolete?". This session will explore the realities of the future of electronic data capture (EDC) along with alternatives to allow for easier and more flexible data capture from all sources and real time access to data to help Sponsors make much faster decisions.

Connelly joins a wide array of innovative industry speakers at this two-day conference to explore and address the latest in innovative thinking to make clinical trials more affordable, efficient, with higher quality data and a far better experience for patients.

Attendees will also have the opportunity to visit Cmed at booth #22 to learn more about the company's significant experience in bringing innovation to the design and conduct of clinical trials, particularly in oncoogy and rare diseases, and its development and deployment of advanced data capture and management technology.



If you would like to pre-arrange a meeting with Cmed at Dpharm: Disruptive Innovations to Advance Clinical Trials, or find out more about any of Cmed's services, contact [email protected].

- ends -


About Cmed

Cmed is an innovative full service CRO and a software developer of smart e-clinical data capture and management technologies. Cmed was established in 2000 with the vision to conduct clinical trials better than anyone else, thus saving and helping lives. Cmed has a focus on bringing innovation to the design and conduct of clinical trials, including in the areas of clinical data capture, data management, monitoring. Cmed has two divisions: Cmed Clinical Services and Cmed Technology.

Cmed Clinical Services is a global CRO providing services to the Biopharma industry worldwide. Cmed works with clients to not only deliver the clinical trial services effectively, and with quality, passion, teamwork and superior customer service, but also, especially for full service projects, by understanding the clients commercial and business objectives. Cmed then leverages its in-depth expertise to ensure the development program and/or clinical trial is well designed and conducted as efficiently and as cost effectively as possible. Cmed has particular expertise in the design and conduct of complex, oncology and rare disease trials and the provision of Biometric functional services.

Cmed Technology designed and developed Timaeus: a unique single platform for electronic trial design, paper & electronic data capture, monitoring, coding, data management and reporting. Using distributed cloud computing and mobile technologies, Timaeus has been deployed in over 400 clinical trials and has successfully passed multiple audits. The unique Timaeus design provides a number of benefits to our clients including rapid database build (weeks not months), mid-trial updates without down-time and non-reliance on the internet. These benefits lead to many advantages including the removal of EDC build from study start-up, no restriction on investigator site selection, no negative impact on recruitment timelines due to design changes, and elevated investigator motivation.


[ Back To TMCnet.com's Homepage ]